Nac Global Technologies, Inc. – ‘DEFA14C’ on 7/23/03

On:  Wednesday, 7/23/03, at 11:59am ET   ·   Effective:  7/23/03   ·   Accession #:  1010412-3-165   ·   File #:  0-49655

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Additional Definitive Proxy Information Statement   —   Schedule 14C
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEFA14C     Additional Definitive Proxy Information Statement      9±    37K 
 2: EX-99       Miscellaneous Exhibit                                  2±    10K 
 3: EX-99       Miscellaneous Exhibit                                  1      7K 

DEFA14C   —   Additional Definitive Proxy Information Statement
Document Table of Contents

DEFA14C
1st “Page” of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SCHEDULE 14C INFORMATION          

Information Statement Pursuant to Section 14(c) of the Securities Exchange Act  
of 1934                                                                         

Check the appropriate box:                                                      

[ ]  Preliminary Information Statement                                          

[ ]  Confidential, for Use of the Commission Only (as permitted by Rule 14c-    
5(d)(2))                                                              

[X]  Definitive Information Statement                                           

ANTICLINE URANIUM, INC.             
(Name of Registrant as Specified in its Charter)        

Payment of Filing Fee (Check the appropriate box):                              

[X]  No fee required                                                            

[ ]  Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.      

(1)  Title of each class of securities to which transaction applies:  N/A.      

(2)  Aggregate number of securities to which transaction applies:  N/A.         

(3)  Per unit price or other underlying value of transaction computed           
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the 
filing fee is calculated and state how it was determined):  N/A.      

(4)  Proposed maximum aggregate value of transaction:  N/A.                     

(5)  Total fee paid:  N/A.                                                      

[ ]  Fee paid previously with preliminary materials.                            

[ ]  Check box if any part of the fee is offset as provided by Exchange Act     
  Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously.  Identify the previous filing by registration number,
or the Form or Schedule and the date of its filing.                   

(1)   Amount Previously Paid:  $0.                            

(2)   Form, Schedule or Registration Statement No.:  N/A      

(3)   Filing Party:  N/A                                      

(4)   Date Filed:  N/A                                        

Contact Persons: Leonard W. Burningham, Esq.                                    
Branden T. Burningham, Esq.                   
Suite 205, 455 East 500 South Street          
Salt Lake City, Utah 84111                    
Tel: 801-363-7411; Fax: 801-355-7126          

DEFA14C
2nd “Page” of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ANTICLINE URANIUM, INC.         
3098 South Highland Drive, Suite 323        
Salt Lake City, Utah 84106          
INFORMATION STATEMENT           

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE         
REQUESTED NOT TO SEND A PROXY       

INTRODUCTION            

     This Information Statement is being furnished to our stockholders
(Anticline Uranium, Inc., a Nevada corporation [the "Company," "Anticline,"     
"we", "our" or "us" or words or similar import]), regarding two amendments to   
our Articles of Incorporation.                                                  

These amendments were unanimously adopted by our Board of   
Directors, and the sole majority stockholder of our Company, LipidViro Tech,    
Inc., a Utah corporation (the "Majority Stockholder"), in accordance with the   
Nevada Revised Statutes (the "Nevada Law").  The Majority Stockholder owns      
5,000,000 shares or approximately 96% of our outstanding voting securities.     
No other votes were required or necessary to adopt these amendments, and none   
are being solicited hereunder.  See the captions "Voting Securities and         
Principal Holders Thereof" and "Amendments to the Articles of Incorporation     
and Vote Required for Approval," herein.                                        

   The amendments to our Articles of Incorporation are as follows.

Increase in authorized shares.                              
------------------------------                              

       Our Board of Directors and majority stockholder have voted to amend
Article Three of our Articles of Incorporation to say:                          

Article Three - - Authorized Shares       

       The number of shares that the Corporation is authorized to issue is
one hundred and fifty million (150,000,000) shares, having a par value of one   
mill or one-tenth cent ($0.001) per share, and the Corporation is authorized    
to issue, and/or grant options and/or warrants to purchase, or otherwise        
acquire, shares of the common stock of the Corporation, upon such terms and     
for such consideration as the Board of Directors of the Corporation shall       
determine.  All shares of stock of this Corporation shall be of the same        
class, namely, common capital shares, and shall have the same rights and        
preferences.  Fully paid shares of stock of this Corporation shall not be       
subject to any further call or assessment.  The Corporation shall have the      
right to purchase, take or otherwise acquire its own shares to the full extent  
permitted under Nevada law.                                                     

 The new Article Three increases the authorized capital of our
Company from $50,000 divided into 50,000,000 shares of $0.001 par value common  
stock to $150,000 divided into 150,000,000 shares of $0.001 par value common    
stock.  No other changes were made in this Article Three.                       

  The Board of Directors believes that this amendment will provide
us with greater flexibility by increasing our authorized capital to allow us    
to issue up to an additional 100,000,000 shares, though there are no current    
plans of our Company that would result in the issuance of the additional        
authorized shares.                                                              

Authorization to Change Name.                               
-----------------------------                               

      Our Board of Directors and majority stockholder have also voted to
add the following new Article Eighteen to our Articles of Incorporation:        

Article Eighteen - - Board of Director Authorization to Change Corporate  
Name                

     The Board of Directors shall have the right to change the name of
the Corporation without shareholder approval to a name that reflects the        
industry or business in which the Corporation's business operations are         
conducted or to a name that will promote or conform to any principal product,   
technology or other asset of the Corporation that the Board of Directors, in    
its sole discretion, deems appropriate.                                         

   In the future, the Company's Board of Directors intends for the
Company to succeed to the business operations of its 96% stockholder,           
LipidViroTech, Inc. (the "Parent"), through a merger or acquisition.  Upon the  
completion of such a transaction, the Company would change its name to          
"LipidViro Tech, Inc." or some other name that would more accurately reflect    
its new business operations.  We believe that the amendment  will also save     
time, cost and expense, in the future, if this discretion is exercised.         
The Company does not have any immediate intention to engage in any such         
transaction.  The operations of the Parent have been disclosed in a Current     
Report on Form 8-K, which the Company filed on June 27, 2003.                   

APPROXIMATE DATE OF MAILING: July 23, 2003.       

DEFA14C
Last “Page” of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
        These amendments will become effective on the opening of business on
August 13, 2003, or a date that is at least 21 days from the mailing of this    
Information Statement to our stockholders.                                      

     These amendments are the only matters covered by this Information
Statement.                                                                      

DISSENTERS' RIGHTS      

       There are no dissenters' rights applicable to the amendments to our
Articles of Incorporation.                                                      

INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON   

       No director, executive officer, nominee for election as a director,
associate of any director, executive officer or nominee or any other person     
has any substantial interest, direct or indirect, by security holdings or       
otherwise, in the proposed amendments to our Articles of Incorporation which    
is not shared by all other stockholders.                                        

VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF     

Voting Securities.                                                              
------------------                                                              

     The securities that would have been entitled to vote if a meeting
was required to have been held regarding these amendments to our Articles of    
Incorporation consist of shares of our common stock.  Each share of our common  
stock is entitled to one vote.  The number of outstanding shares of our common  
stock at the close of business on June 27, 2003, the record date for            
determining our stockholders who would have been entitled to notice of and to   
vote on the amendment to our Articles of Incorporation, was 5,213,112.          

Security Ownership of Principal Holders and Management.                         
-------------------------------------------------------                         

     The following table sets forth certain information as of June 27,
2003, regarding current beneficial ownership of the shares of our common stock  
by (i) each person known by us to own more than 5% of the outstanding shares    
of our common stock, (ii) each of our executive officers and directors, and     
(iii) all of our executive officers and directors as a group.  Except as        
noted, each person has sole voting and sole investment or dispositive power     
with respect to the shares shown.  The information presented is based on        
5,213,112 outstanding shares of common stock.                                   

                     Positions               Number and Percentage
Name and Address               Held              of Shares Beneficially Owned*  
----------------               ----              -----------------------------  

Kenneth P. Hamik*          President, CEO             5,000,000 - 96%           
1506 California St.         and Director                                        
Berkeley, CA 94703                                                              

Kristy Hamik*             COO and Director            5,000,000 - 96%           
2120 South 700 East, #H183                                                      
Salt Lake City, Utah 84106                                                      

LipidViro Tech, Inc.*        Stockholder              5,000,000 - 96%           
2120 South 700 East, #H183                                                      
Salt Lake City, Utah  84106                                                     

All executive officers and directors                  5,000,000 - 96%           
of the Company as a group (2 persons)*                                          

   * Kenneth P. Hamik and Kristy Hamik, cousins, are directors and
        executive officers and minor stockholders of LipidViro, who were
      designated to serve as directors and executive officers of the
          Registrant on June 25, 2003, accordingly, they may be deemed to be
          the beneficial owners of the outstanding shares of common stock of
      the Registrant that are owned by LipidViro as indicated in the
   foregoing table.  See the heading "Contractual Arrangements

Regarding Changes in Control" of the caption "Voting Securities                 
and Principal Holders Thereof," below.                                          

Contractual Arrangements Regarding Changes in Control.                          
------------------------------------------------------                          

      On June 24, 2003, a Share Purchase Agreement (the "Agreement") was
executed by and between North Beck Joint Venture, LLC, a Utah limited           
liability company ("North Beck"), and the owner of approximately 96% of the     
outstanding voting securities of the Registrant, as "Seller," and LipidViro     
Tech, Inc., a Utah corporation ("LipidViro"), as "Buyer."                       

        By virtue of (i) the percentage of the Registrant acquired under the
Agreement by LipidViro; and (ii) the subsequent resolution of the Board of      
Directors of the Registrant that provided for the election of the current       
directors and executive officers of LipidViro to the Board of Directors of the  
Registrant and the resignation of the current directors and executive officers  
of the Registrant, this Agreement is deemed to have involved a "change of       
control" of the Registrant.                                                     

    The source of the consideration used by LipidViro to acquire its
interest in the Registrant was cash from working capital.                       

      The primary basis of the "control" by LipidViro is stock ownership
and/or management positions.                                                    

  Prior to the completion of the Agreement, there were 5,213,112
outstanding shares of the Registrant's common stock, and an additional 500,000  
shares that had been authorized to be issued to John Michael Coombs, Esq. and   
Terry S. Pantelakis, who served as directors and executive officers of the      
Company at the time of the closing of the Agreement.  Following the closing of  
the Agreement and the cancellation of the 500,000 authorized to be issued but   
not outstanding shares of Messrs. Coombs and Pantelakis, there were 5,213,112   
outstanding shares of the Registrant's common stock.                            

CERTAIN INFORMATION REGARDING DIRECTORS AND EXECUTIVE OFFICERS  

Directors and Executive Officers.                                               
---------------------------------                                               

     The following delineates certain information concerning our newly
designated directors and executive officers:                                    
                                                   Positions
                       Positions with               with
Name            Age        the Company              LipidViro 
----            ---        -----------              ----------

Kenneth P. Hamik         45         President, CEO           President, CEO     
                             and Director             and Director

Kristy Hamik             35         COO and Director         COO and Director   

     Directors are elected by our stockholders to serve until the next
annual meeting of our stockholders or until their successors have been elected  
and have duly qualified.  Officers are appointed to serve until the annual      
meeting of our Board of Directors following the next annual meeting of our      
stockholders and until their successors have been elected and have qualified.   

        The following is a summary of the business experience of each of our
current directors and executive officers:                                       

   Kenneth P. Hamik has over 20 years of management and consulting
experience across a wide range of markets: healthcare, media/entertainment,     
consumer products, Internet, education, financial services,                     
telecommunications, energy, electronics/computers, air travel and auto          
manufacturing.  He was featured in the January 2000 cover article of Consumer   
Reports on future product trends, in an MSN article on future career paths,     
and recently headed a team to manage Charles Schwab electronic relationship     
management strategies.  Before joining LipidViro, he served as Vice             
President of Marketing & Strategy at Triple Aught, Inc., a Berkeley,            
California based energy technology & engineering start-up company.  Ken         
completed his Masters of Science work at the University of Houston's Studies    
of the Future program.  He also has a B.S. Degree from the University of        
Nebraska.                                                                       

Over the past five years, Kristy Hamik has had substantial  
leadership and professional experience.  She is the founder and CEO of          
WebEducation Network.  She designed education networks for global groups,       
facilitated training seminars, acted as editor and project manager of           
published articles and books. Over the past three years, Ms. Hamik also served  
as education director at American Bible Society overseeing all educational      
programs and content for both web and print projects.  Ms.Hamik received a      
Bachelor of Arts Degree from the University of California at Berkeley,          
California, in 1992; a Masters of Education from Mills College, Oakland,        
California, in 1994; and completed a Doctorate of Philosophy of Education from  
Columbia University in 1999.                                                    

Family Relationships.                                                           
---------------------                                                           

Kenneth P. Hamik and Kristy Hamik are cousins.              

Pending Legal Proceedings.                                                      
--------------------------                                                      

To the knowledge of our management, no director or executive
officer is party to any action in which any has an interest adverse to us.      

Involvement in Certain Legal Proceedings.                                       
-----------------------------------------                                       

        Except as indicated at the end of this heading, and to the knowledge
of our management and during the past 10 years, no present or former director,  
person nominated to become a director, executive officer, promoter or control   
person of our Company:                                                          

   (1)  Was a general partner or executive officer of any business
    by or against which any bankruptcy petition was filed,
   whether at the time of such filing or two years prior
thereto;                                          

    (2)  Was convicted in a criminal proceeding or named the subject
 of a pending criminal proceeding (excluding traffic
violations and other minor offenses);             

(3)  Was the subject of any order, judgment or decree, not  
          subsequently reversed, suspended or vacated, of any court of
          competent jurisdiction, permanently or temporarily enjoining
       him from or otherwise limiting, the following activities:

       (i)  Acting as a futures commission merchant, introducing
         broker, commodity trading advisor, commodity pool
              operator, floor broker, leverage transaction merchant,
           associated person of any of the foregoing, or as an
            investment adviser, underwriter, broker or dealer in
           securities, or as an affiliated person, director or
             employee of any investment company, bank, savings and
             loan association or insurance company, or engaging in
           or continuing any conduct or practice in connection
with such activity;                     

(ii) Engaging in any type of business practice; or

 (iii) Engaging in any activity in connection with the
        purchase or sale of any security or commodity or
      in connection with any violation of federal or
    state securities laws or federal commodities
laws;                                   

(4)  Was the subject of any order, judgment or decree, not  
         subsequently reversed, suspended or vacated, of any federal
          or state authority barring, suspending or otherwise limiting
         for more than 60 days the right of such person to engage in
    any activity described above under this Item, or to be
   associated with persons engaged in any such activity;
  (5)  Was found by a court of competent jurisdiction in a civil
         action or by the Securities and Exchange Commission to have
   violated any federal or state securities law, and the
        judgment in such civil action or finding by the Securities
         and Exchange Commission has not been subsequently reversed,
suspended, or vacated; or                         

  (6)  Was found by a court of competent jurisdiction in a civil
      action or by the Commodity Futures Trading Commission to
         have violated any federal commodities law, and the judgment
      in such civil action or finding by the Commodity Futures
    Trading Commission has not been subsequently reversed,
suspended or vacated.                             

      Kenneth P. Hamik filed for personal bankruptcy under Chapter 13 of
the Bankruptcy Code in California in February, 2002, which was discharged in    
February 2003, with all creditors being paid in full.                           

Executive Compensation.                                                         
-----------------------                                                         

      None of our present directors and executive officers have received
any cash or other remuneration for services rendered to us; and no              
compensatory arrangements have yet been set for service in these capacities.    
Previous director and executive compensation amounted to granting an aggregate  
of 500,000 shares of common stock of our Company to Messrs. Coombs and          
Pantelakis, which shares were cancelled to our treasury in connection with the  
closing of the change of control transaction outlined under the heading         
"Contractual Arrangements Regarding Changes in Control" of the caption "Voting  
Securities and Principal Holders Thereof," above.  These 500,000 shares had     
been authorized to be issued, but were not outstanding on the date of their     
cancellation.                                                                   

      We do not have any stock option, bonus, profit sharing, pension or
similar plan; however, we may adopt such a plan in the future to attract        
and/or retain members of management or key employees.                           

Compliance with Section 16(a) of the Exchange Act.                              
--------------------------------------------------                              

     All reports required to be filed pursuant to Section 16(a) of the
Exchange Act have been timely filed.                                            

Audit, Nominating and Compensation Committees.                                  
---------------------------------------------                                   

    The Company has no audit, nominating or compensation committees.

AMENDMENT TO THE ARTICLES OF INCORPORATION      
AND VOTE REQUIRED FOR APPROVAL      

Nevada Law.                                                                     
-----------                                                                     

        Section 390 of the Nevada Law provides that every amendment to the
Articles of Incorporation of a corporation shall first be adopted by the        
resolution of the Board of Directors and then be subject to the approval of     
persons owning a majority of the securities entitled to vote on any such        
amendment.  Sections 315 and 320, respectively, provide that the Board of       
Directors, by unanimous written consent, and persons owning the required        
majority of voting securities necessary to adopt any action that would          
otherwise be required to be submitted to a meeting of stockholders, may adopt   
such action without a meeting by written consent.                               

      Resolutions to effect these amendments were unanimously adopted by
our Board of Directors and the Majority Stockholder named under the caption     
"Voting Securities and Principal Holders Thereof."  The Majority Stockholder    
owns approximately 96% of our outstanding voting securities.   No other votes   
or consents are required or necessary to effect the amendments.                 

Effective Date of Amendment.                                                    
----------------------------                                                    

  The effective date of the amendment to increase our authorized
capital will be on the opening of business on August 13, 2003, or 21 days from  
the mailing of this Information Statement to our stockholders.                  

NOTICE        

THE MAJORITY STOCKHOLDER OF OUR COMPANY THAT HAS CONSENTED TO THE ADOPTION OF   
THESE AMENDMENTS TO OUR ARTICLES OF INCORPORATION OWNED IN EXCESS OF THE    
REQUIRED NUMBER OF OUR OUTSTANDING VOTING SECURITIES TO ADOPT THESE AMENDMENTS  
UNDER NEVADA LAW, AND HAS DONE SO. NO FURTHER CONSENTS, VOTES OR  
PROXIES ARE NEEDED, AND NONE ARE REQUESTED.   

              BY ORDER OF THE BOARD OF DIRECTORS

July 22, 2003                 Kenneth P. Hamik                                  

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘DEFA14C’ Filing		Date		First		Last			Other Filings
		8/13/03		3					8-K/A,  NT 10-Q
Filed on / Effective on:		7/23/03		2
		7/22/03		3					DEF 14C
		6/27/03		2		3			8-K,  PRE 14C
		6/25/03		3					3,  4,  SC 13D
		6/24/03		3					3,  4,  8-K
									List all Filings